Ledipasvir

Overview

Ledipasvir is a direct-acting antiviral agent used in combination with sofosbuvir for the treatment of chronic hepatitis C virus (HCV) infection. It works by inhibiting the HCV NS5A protein, which is essential for viral replication.

API suppliers (1)

Suppliers of Ledipasvir backed by a verifiable FDA Type II Drug Master File. Source: FDA quarterly DMF list.

• Lupin LimitedIndia

Therapeutic areas